[Form 4] Lionsgate Studios Corp. Insider Trading Activity

Rhea-AI Filing Summary

Lionsgate Studios Corp. director Susan McCaw reported equity compensation in the form of common shares and restricted share units. On 11/28/2025, she acquired 20,107 common shares at a price of $0 as part of her annual director equity award, bringing her beneficial ownership to 101,026 common shares.

Her holdings include restricted share units that convert into an equal number of common shares when they vest. These comprise 20,066 units scheduled to vest on November 29, 2025 and 20,107 units scheduled to vest on November 28, 2026. She has elected to defer payment of the vested 2026 units until the earlier of leaving the board or the tenth anniversary of vesting.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider McCaw Susan

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares	0	$7.46	--
Grant/Award	Common Shares	20,107	$0.00	--

Holdings After Transaction: Common Shares — 101,026 shares (Direct)

Footnotes (1)

1. Annual director equity award. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,066 restricted share units that are scheduled to vest on November 29, 2025; and (ii) 20,107 restricted share units that are scheduled to vest on November 28, 2026. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026. The reporting person has elected to defer payment of the vested units until the first the occur of termination of service on the Issuer's board or the tenth anniversary of vesting.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCaw Susan

(Last) (First) (Middle)

LIONSGATE

2700 COLORADO AVENUE

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/28/2025		A		20,107(1)	A	$0	101,026(2)	D
Common Shares	11/29/2025		F		0	D	$7.46	101,026(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual director equity award.

2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,066 restricted share units that are scheduled to vest on November 29, 2025; and (ii) 20,107 restricted share units that are scheduled to vest on November 28, 2026.

3. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026. The reporting person has elected to defer payment of the vested units until the first the occur of termination of service on the Issuer's board or the tenth anniversary of vesting.

Remarks:

	Susan McCaw (By Adrian Kuzycz by Power of Attorney)	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.